Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers

Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers

Background: Fecal immunochemical tests (FITs) are widely used for colorectal cancer (CRC) screening. The detection of early-stage cancer and advanced adenoma (AA), the most important premalignant lesion, is highly relevant to reducing CRC-related deaths. We aimed to assess sensitivity for the detect...

Full description

Bibliographic Details
Main Authors:	Anton Gies, Tobias Niedermaier, Laura Fiona Gruner, Thomas Heisser, Petra Schrotz-King, Hermann Brenner
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	Cancers
Subjects:	colon cancer fecal occult blood test advanced neoplasia early detection prevention
Online Access:	https://www.mdpi.com/2072-6694/13/4/644

Similar Items

Combination of Different Fecal Immunochemical Tests in Colorectal Cancer Screening: Any Gain in Diagnostic Performance?
by: Anton Gies, et al.
Published: (2019-01-01)

Consistent Major Differences in Sex- and Age-Specific Diagnostic Performance among Nine Faecal Immunochemical Tests Used for Colorectal Cancer Screening
by: Anton Gies, et al.
Published: (2021-07-01)

The Effects of Different Invitation Schemes on the Use of Fecal Occult Blood Tests for Colorectal Cancer Screening: Systematic Review of Randomized Controlled Trials
by: Laura F. Gruner, et al.
Published: (2021-03-01)

Clinical Utility of Fecal Immunochemical Transferrin Test in Gastrointestinal Bleeding Detection
by: Jong-Mi Lee, et al.
Published: (2018-09-01)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
by: Efrat L. Amitay, et al.
Published: (2019-03-01)

The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort
by: Gonzalo Hijos-Mallada, et al.
Published: (2021-06-01)

Accuracy of a fecal immunochemical test according to outside temperature and travel time
by: Niedermaier T, et al.
Published: (2018-09-01)

Higher satisfaction with an alternative collection device for stool sampling in colorectal cancer screening with fecal immunochemical test: a cross-sectional study
by: Hye Young Shin, et al.
Published: (2018-04-01)

Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?
by: Joanne M. Osborne, et al.
Published: (2017-08-01)

Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option
by: Flitcroft Kathy L, et al.
Published: (2012-12-01)

Embedded Immunodetection System for Fecal Occult Blood
by: Kai-Wen Lin, et al.
Published: (2021-04-01)

Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population
by: Brenner H, et al.
Published: (2017-07-01)

How Does Colonoscopy Compare with Fecal Occult Blood Testing as a Screening Tool for Colon Cancer?
by: Boggs, Bruce D., et al.
Published: (2005)

Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis
by: Natsuki Ishida, et al.
Published: (2020-04-01)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
by: Dong Ju Kim, et al.
Published: (2018-10-01)

Assessment of fecal calprotectin and fecal occult blood as point-of-care markers for soil-transmitted helminth attributable intestinal morbidity in a case-control substudy conducted in Côte d'Ivoire, Lao PDR and Pemba Island, Tanzania
by: Chandni Patel, et al.
Published: (2021-02-01)

Validación de técnica inmunoquímica para detección de sangre oculta en heces
by: Olga Marina Hano García, et al.

Collection of non-meconium stool on fecal occult blood cards is an effective method for fecal microbiota studies in infants
by: Wendy S.W. Wong, et al.
Published: (2017-09-01)

Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
by: Jun Kato, et al.
Published: (2016-01-01)

Role of Immunological Method of Fecal Occult Blood Test for Screening Colorectal Diseases
by: Farida Yeasmin, et al.
Published: (2011-09-01)

Utilization of fecal occult blood test in the acute hospital setting and its impact on clinical management and outcomes
by: S Mosadeghi, et al.
Published: (2016-01-01)

Use and abuse of fecal occult blood tests: a community hospital experience
by: Sarthak Soin, et al.
Published: (2019-09-01)

FECAL OCCULT BLOOD: A COMPARISON OF CHEMICAL AND IMMUNOCHEMICAL TESTS
by: Luana Vilarinho BORGES, et al.

Fecal Hemoglobin Concentration, a Good Predictor of Risk of Advanced Colorectal Neoplasia in Symptomatic and Asymptomatic Patients
by: Mercedes Navarro, et al.
Published: (2019-05-01)

A Comparative Study of Three Fecal Occult Blood Tests in Upper Gastrointestinal Bleeding
by: Chien-Hua Chiang, et al.
Published: (2006-05-01)

Variation of diagnostic performance of fecal immunochemical testing for hemoglobin by sex and age: results from a large screening cohort
by: Brenner H, et al.
Published: (2018-04-01)

Usefullness of routine use of fecal occult blood test in a hospital setting
by: Simona Ravnik, et al.
Published: (2006-12-01)

Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study
by: Elizabeth G. Liles, et al.
Published: (2018-05-01)

Evaluation of Two Fecal Occult Blood Tests for Detecting Non-perforating Abomasal Lesions in Cattle
by: Sara Lee Munch, et al.
Published: (2020-12-01)

Clinical Factors Associated with Adherence to the Follow-Up Examination after Positive Fecal Occult Blood Test in National Colorectal Cancer Screening
by: Byung Chang Kim, et al.
Published: (2020-01-01)

Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial
by: Carrie M. Nielson, et al.
Published: (2018-09-01)

Endoscopic Treatment of Solitary Colonic Ganglioneuroma
by: Toshio Arai, et al.
Published: (2020-01-01)

Diagnostic accuracy of fecal calprotectin in predicting significant gastrointestinal diseases
by: Yee Man Kan, et al.
Published: (2021-06-01)

Factors Associated with the Use of Fecal Immunochemical Tests and Colonoscopy in the INSEF Portuguese Population
by: Fábio Sousa Gomes, et al.
Published: (2021-06-01)

Inmunoexpresión p53, sangre oculta en heces de pacientes colecistectomizados y colelitiasis con adenomas colónicos
by: Felipe Neri Piñol Jiménez, et al.

Colorectal Cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015–2016
by: Aysha Almansoori, et al.
Published: (2021-08-01)

Polyprev: Randomized, Multicenter, Controlled Trial Comparing Fecal Immunochemical Test with Endoscopic Surveillance after Advanced Adenoma Resection in Colorectal Cancer Screening Programs: A Study Protocol
by: Cristina Regueiro, et al.
Published: (2021-08-01)

A Novel Insight Into Fecal Occult Blood Test for the Management of Gastric Cancer: Complication, Survival, and Chemotherapy Benefit After R0 Resection
by: Jun Lu, et al.
Published: (2021-02-01)

Targeting the microbiome: from probiotics to fecal microbiota transplantation
by: Alexander Khoruts
Published: (2018-10-01)

Detection of Colorectal Cancer and Advanced Adenoma by Liquid Biopsy (Decalib Study): The ddPCR Challenge
by: Audelaure Junca, et al.
Published: (2020-06-01)